Cell-based Analysis: Sales/Orders of Note
Cyntellect received a $1.3 million Phase II Small Business Innovative Research (SBIR) grant to continue development of its LEAP system for automated purification and the cloning of cells based on specific secretion of native or recombinant proteins.
Fluxion Biosciences received a $1.2 million Phase II SBIR grant from the National Institutes of Health for the development of a multiplexed single-cell electroporation system.
< Previous Article | Next Article >